Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

The Frontier Trial – Field Randomization of NA-1 Treatment In Early Responders

Project Overview

Stroke is a life threatening emergency caused by blocked arteries that affects 45,000 Canadians a year. Each hour a stroke is left untreated means brain cells are dying. The only emergency treatment we have is a clot busting agent that can re-open blocked arteries if given within 3-4.5 hours of the onset of stroke symptoms. Unfortunately only 5-11% of all Canadian stroke victims receive this treatment. If we could administer a treatment that could slow down or halt the damaging effects of stroke early after calling 911 it may improve outcomes. NA-1 is a drug developed by Canadian scientists which can be given to most stroke victims. This drug has been shown in the laboratory, in animals and in a small number of patients undergoing brain surgery, that it has the ability to reduce damage of a stroke and improve brain function. The FRONTIER trial is designed to identify stroke patients early after calling 911 and compare outcomes when paramedics randomly (toss of a coin) give either NA-1 or a salt solution called a placebo and transport the patient to the closest stroke centre. the team will follow the patients for up to 90 days after receiving the study drug to evaluate their brain function. In the past, over 200 promising agents have been tested without identifying any that could help in stroke. All of these were given in the emergency department hours after the stroke began. The team is hopeful that moving the drug into the hands of the paramedics will enable the drug effect to begin early and to provide the protection the brain needs to endure a stroke and minimize the brain damage.

Principal Investigator

Jim Christenson , University of British Columbia

Team Members

Oscar Benavente, University of British Columbia

William Dick, B.C. Emergency Health Services

Partners and Donors

St. Michaels Hospital

Canadian Stroke Network

Genome BC

Djavad Mowafaghian Centre for Brain Health

University of British Columbia

Project Ongoing

The Frontier Trial – Field Randomization of NA-1 Treatment In Early Responders

  • Grant Type

    Team grants

  • Area of research

    Injury

  • Disease Area

    Stroke

  • Competition

    2014 MIRI Team Grants

  • Province

    British Columbia

  • Start Date

    2016

  • Total Grant Amount

    $8,068,664

  • Health Canada Contribution

    $3,956,135

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co